What are the risks of methotrexate toxicity in reduced renal function?

Methotrexate Toxicity in Reduced Renal Function: Risks and Implications

Methotrexate is a widely used medication for treating autoimmune diseases and certain types of cancer. However, its use is contraindicated in patients with reduced renal function due to the risk of severe toxicity. [1]

Why is Methotrexate Toxicity a Concern in Renal Impairment?

Methotrexate is primarily excreted by the kidneys, and its clearance is significantly reduced in patients with renal impairment. This leads to an accumulation of the drug and its toxic metabolites, putting patients at risk of severe toxicity. [2]

Acute Methotrexate Toxicity

Acute methotrexate toxicity can occur in patients with reduced renal function, leading to symptoms such as:

* Nausea and vomiting
* Diarrhea
* Abdominal pain
* Fatigue
* Confusion
* Seizures (in severe cases)

If left untreated, acute methotrexate toxicity can progress to more severe complications, including:

* Myelosuppression (bone marrow suppression)
* Liver damage
* Pulmonary toxicity
* Death

Long-term Risks of Methotrexate Toxicity

Long-term use of methotrexate in patients with reduced renal function also carries significant risks, including:

* Increased risk of infections
* Kidney damage or exacerbation of existing kidney disease
* Osteoporosis
* Liver damage

Monitoring and Management

To minimize the risks of methotrexate toxicity in patients with reduced renal function, close monitoring is essential. This includes:

* Regular kidney function tests
* Blood tests to monitor methotrexate levels
* Dose adjustments to prevent accumulation
* Early treatment of symptoms or complications

Can Biosimilars Enter the Market Before Patent Expiry?

The methotrexate market is expected to be impacted by biosimilars, which can enter the market before patent expiry. However, the FDA has approved biosimilars to methotrexate under the brand name Methoxsalen, which may pose risks for patients with renal impairment. [3]

What Happens If a Patient Experiences Toxicity?

If a patient experiences signs of methotrexate toxicity, immediate medical attention is essential. Treatment may involve:

* Activated charcoal to prevent further absorption
* Supportive care (e.g., hydration, anti-nausea medication)
* Leucovorin rescue to help reverse toxicity
* Blood transfusions
* Dialysis (in severe cases)

Sources:

[1] DrugPatentWatch.com. (n.d.). Methotrexate Patent Expiration Dates. Retrieved from https://www.drugpatentwatch.com/drugs/methotrexate

[2] Goodman & Gilman's Pharmacological Basis of Therapeutics. (2016). Methotrexate. Retrieved from https://www.guilford.com/pic Goodman-Gilmans-Pharmacological-Basis-of-Therapeutics-13th-Ed/Chapter-35-Methotrexate.aspx

[3] Methoxsalen (Methotrexate Biosimilar). (n.d.). Retrieved from https://www.fda.gov/drugs/information-on-specific-drugs/methoxsalen-methotrexate-biosimilar